BPGbio

BPGbio, a biopharmaceutical firm, employs artificial intelligence to simulate patient biology. Its objective is to enhance the quality and predictability of drug targets, as well as refine clinical trial designs and outcomes. Specializing in oncology, neurology, and rare diseases, BPGbio leverages a worldwide network of hospitals and academic medical centers to enrich its biobank, which houses over 100,000 samples, ensuring diversity and depth.